Vasoconstrictor Therapy for the Hepatorenal Syndrome

Gastroenterology

Volumn 134, Issue 5, 2008, Pages 1608-1611

  Lim, Joseph K ^a   Groszmann, Roberto J ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; MIDODRINE; NORADRENALIN; OCTREOTIDE; ORNIPRESSIN; PLACEBO; PLASMA SUBSTITUTE; SOMATOSTATIN DERIVATIVE; TERLIPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEPATORENAL SYNDROME; HUMAN; INTESTINE ISCHEMIA; MONOTHERAPY; PRIORITY JOURNAL; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 42949160592     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.03.034     Document Type: Editorial

References (23)

1. A. Gines A. Escorsell P. Gines Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites Gastroenterology 105 1993 229 236
2. B.A. Runyon Management of adult patients with ascites due to cirrhosis: AASLD practice guidelines Hepatology 39 2004 1 16
3. V. Arroyo P. Gines A.L. Gerbes Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis Hepatology 23 1996 164 176
4. F. Salerno A. Gerbes P. Gines Diagnosis, prevention, and treatment of hepatorenal syndrome in cirrhosis Gut 56 2007 1310 1318
5. Y. Iwakiri R.J. Groszmann The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule Hepatology 43 2 Suppl 1 2006 S121 S131
6. A. Sanyal T. Boyer G. Garcia-Tsao A randomized prospective double-blind placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome Gastroenterology 134 2008 1360 1368
7. M. Martin-Llahi M.N. Pepin M. Guevara Terlipressin and albumin versus albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study Gastroenterology 134 2008 1352 1359
8. P. Angeli R. Volpin G. Gerunda Reversal of type 1 hepato-renal syndrome (HRS) with the combined administration of midodrine and octreotide Hepatology 29 1999 1690 1697
9. M. Eefsen T. Dethloff H.J. Frederiksen Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support J Hepatol 47 2007 381 386
10. M.B. Fallon Hepatopulmonary syndrome: more than just a matter of tone? Hepatology 43 2006 912 914
11. T.A. Gonwa C.A. Morris R.M. Goldstein Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome—experience in 300 patients Transplantation 51 1991 428 430
12. T.A. Gonwa G.B. Klintmalm M. Levy Impact of pretransplant renal function on survival after liver transplantation Transplantation 59 1995 361 365
13. R. Moreau D. Lebrec The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond Hepatology 43 2006 385 394
14. C. Alessandria O. Ozdogar M. Guevara MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation Hepatology 41 2005 1282 1289
15. T. Restuccia R. Ortega M. Guevara Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome: a case-control study J Hepatol 40 2004 140 146
16. A. Hadengue A. Gadano R. Moreau Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome J Hepatol 29 1998 565 570
17. P. Solanski A. Chawla R. Garg Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial J Gastroenterol Hepatol 18 2003 152 156
18. F. Fabrizi V. Dixit P. Martin Meta-analysis: terlipressin therapy for the hepatorenal syndrome Aliment Pharmacol Ther 2006 935 944
19. Gluud LL, Kjaer MS, Christensen E. Terlipressin for hepatorenal syndrome. Cochrane Database Syst Rev 20064:CD005162. DOI: 10.1002/14651858.CD005162.pub2 .
20. R. Ortega P. Gines J. Uriz Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study Hepatology 35 2002 941 948
21. F. Wong L. Pantea K. Sniderman Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepato-renal syndrome Hepatology 40 2004 55 64
22. E. Esrailiam E.R. Pantageo N.L. Kyulo Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepato-renal syndrome Dig Dis Sci 52 2007 742 748
23. D.L. Shawcross N.A. Davies R.P. Mookerjee Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy Hepatology 39 2004 471 475